Cohance Lifesciences Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹441.75Market Cap
₹ 16,906 Cr.Stock P/E
85.7ROE
7.04 %RSI
48.16Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations.[1]
Cohance Lifesciences Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Cohance Lifesciences Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Cohance Lifesciences Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 441.75 |
| RSI (14) | 48.16 |
| 50 DMA | 438.41 |
| 200 DMA | 488.9 |
| Trend | Bullish |
| A/D Rating | A+ |
| RS Rating | 17 |
| EPS Rating | 5 |
| TI65 | 1.01 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Cohance Lifesciences Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹453.79 |
| R2 | ₹448.12 |
| R1 | ₹441.44 |
| PP | ₹435.77 |
| S1 | ₹429.09 |
| S2 | ₹423.42 |
| S3 | ₹416.74 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 16,906 Cr. |
| Current Price | ₹ 442 |
| High / Low | ₹ 1,081 / 267 |
| Stock P/E | 85.7 |
| Book Value | ₹ 102 |
| Dividend Yield | 0.00 % |
| ROCE | 8.35 % |
| ROE | 7.04 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 369.36 | 123.97 | 46.53% |
| Jun 2023 | 347.55 | 120.59 | 48.04% |
| Sep 2023 | 231.05 | 79.56 | 42.40% |
| Dec 2023 | 219.82 | 46.75 | 30.06% |
| Mar 2024 | 252.93 | 53.37 | 29.00% |
| Jun 2024 | 488.08 | 75.37 | 25.63% |
| Sep 2024 | 603.77 | 138.24 | 34.01% |
| Dec 2024 | 676.23 | 153.48 | 35.10% |
| Mar 2025 | 840.42 | 117.15 | 27.27% |
| Jun 2025 | 549.31 | 46.40 | 20.39% |
| Sep 2025 | 555.57 | 66.39 | 21.77% |
| Dec 2025 | 544.55 | 29.02 | 17.51% |
| Mar 2026 | 619.12 | 8.31 | 15.94% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 60.00% |
| FIIs | 0.00% |
| DIIs | 8.19% |
| Government | 0.00% |
| Public | 31.81% |
| No. of Shareholders | 60,684 |
Pros and Cons
Pros
- Strong technical momentum with price holding comfortably above the 50 DMA (438.41).
Cons
- Valuation metrics appear elevated with a trailing P/E of 85.7, demanding high performance requirements.
Related NSE Stocks
Global Health Limited
View Share Price Analysis →Hindalco Industries Limited
View Share Price Analysis →UCO Bank
View Share Price Analysis →National Aluminium Company Limited
View Share Price Analysis →Honeywell Automation India Limited
View Share Price Analysis →Trident Limited
View Share Price Analysis →Motherson Sumi Wiring India Limited
View Share Price Analysis →Sun Pharmaceutical Industries Limited
View Share Price Analysis →Syngene International Limited
View Share Price Analysis →Indian Renewable Energy Development Agency Limited
View Share Price Analysis →Coal India Limited
View Share Price Analysis →Trent Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Cohance Lifesciences Ltd share?
Based on the latest closing data, the technical momentum for Cohance Lifesciences Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 48.16, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (438.41) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Cohance Lifesciences Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Cohance Lifesciences Ltd today centers at a Pivot Point (PP) of ₹435.77. Upside resistance challenges are calculated at R1: ₹441.44, R2: ₹448.12, and R3: ₹453.79. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹429.09, S2: ₹423.42, and S3: ₹416.74.
How does the fundamental ROE and P/E ratio look for Cohance Lifesciences Ltd?
Cohance Lifesciences Ltd is currently trading with a valuation metrics context of a Stock P/E of 85.7, against a core structural efficiency Return on Equity (ROE) standing at 7.04 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 5, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Cohance Lifesciences Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Symmetric Breakout Squeeze Play (Neutral / Monitor Closely). Cohance Lifescience... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of A+, a Relative Strength (RS) ranking of 17, and long-term trend backing from the TI65 indicator (Neutral pattern).